Corey Goodwin

Corey Goodwin

Auto-generated profile, based on publicly available information

Corey Goodwin

Thermo Fisher Scientific, Scoresby, Australia

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2018 in Forensic Science, Medicine and Pathology
Verified
Journal Article
Closed access
PDF file
CGCorey Goodwin
Corey Goodwin
DHDenice Higgins
Denice Higgins
STShanan S. Tobe
Shanan S. Tobe
JAJeremy Austin
Jeremy Austin
AWAndrew Wotherspoon
Andrew Wotherspoon
DMDennis McNevin
Dennis McNevin

16 June 2023 in Journal of Forensic Sciences
Verified
Journal Article
Open access
DBDan Nana Osei Bonsu
Dan Nana Osei Bonsu
DHDenice Higgins
Denice Higgins
CSClaire Simon
Claire Simon
CGCorey S. Goodwin
Corey S. Goodwin
JHJulianne M. Henry
Julianne M. Henry
JAJeremy J. Austin
Jeremy J. Austin
Metals can pose challenges while conducting forensic DNA analysis. The presence of metal ions in evidence‐related DNA extracts can degrade DNA or inhibit PCR as applied to DNA quantification (real‐time PCR or qPCR) and/or STR amplification, leading to low success in STR profiling. Different metal ions were spiked into 0.2 and 0.5 ng of human genomic DNA in an “inhibition study” and the impact was evaluated by qPCR using the Quantifiler™ Trio DNA Quantification Kit (Thermo Fisher Scientific) and an in‐house SYBR Green assay. This study reports on a contradictory finding specific to tin (Sn) ions, which caused at least a 38,000‐fold overestimation of DNA concentration when utilizing Quantifiler Trio. This was explained by the raw and multicomponent spectral plots, which indicated that Sn suppresses the Quantifiler Trio passive reference dye (Mustang Purple™, MP) at ion concentrations above 0.1 mM. This effect was not observed when DNA was quantified using SYBR Green with ROX™ as the passive reference, nor when DNA was extracted and purified prior to Quantifiler Trio. The results show that metal contaminants can interfere with qPCR‐based DNA quantification in unexpected ways and may be assay dependent. The results also highlight the importance of qPCR as a quality check to determine steps for sample cleanup prior to STR amplification that may be similarly impacted by metal ions. Forensic workflows should recognize the risk of inaccurate DNA quantification of samples that are collected from substrates containing tin.

12 July 2020 in Forensic Science, Medicine and Pathology
Verified
Journal Article
Closed access
PDF file
CGCorey Goodwin
Corey Goodwin
AWAndrew Wotherspoon
Andrew Wotherspoon
MGMichelle E. Gahan
Michelle E. Gahan
DMDennis McNevin
Dennis McNevin

15 October 2024 in International journal of legal medicine
Verified
Journal Article
Open access
PDF file
DMDennis McNevin
Dennis McNevin
Jessica WatsonJessica Watson
Jessica Watson
KGKelly Grisedale
Kelly Grisedale
ADAyusha Dahal
Ayusha Dahal
CGCorey Goodwin
Corey Goodwin
JWJodie Ward
Jodie Ward
Targeted amplicon sequencing (TAS) facilitates the genotyping of forensically informative single nucleotide polymorphisms (SNPs) using massively parallel sequencing (MPS). For human remains identification, where any extracted DNA is likely to be degraded, TAS may succeed when short tandem repeat (STR) profiling using capillary electrophoresis fails. Further, as well as yielding identity information, SNPs can provide information about ancestry, phenotype, kinship and paternal lineage (Y chromosome haplotypes). Two TAS platforms were compared in this study: Ion AmpliSeq™ panels coupled with Ion Torrent sequencing on an Ion GeneStudio™ S5 Plus System, manufactured by Thermo Fisher Scientific, and the ForenSeq® Kintelligence Kit coupled with Illumina sequencing on the MiSeq FGx® Sequencing System, manufactured by QIAGEN. Four Ion AmpliSeq™ panels (Precision ID Identity, Precision ID Ancestry, DNA Phenotyping and HID Y-SNP) share 177 SNPs with the ForenSeq® Kintelligence Kit and all five were used to profile the DNA extracted from the petrous part of the temporal bone from six skeletonised cadavers. Of the 6 × 177 = 1,062 SNP genotype comparisons, 1,055 (99%) were concordant between the Ion AmpliSeq™ panels and Kintelligence Kit. Of the seven (< 1%) non-concordant SNPs, only three of them (0.3%) would have resulted in erroneous genotypes being reported as a result of allele dropout by either assay, using our optimised relative variant frequency windows for allele calling. We conclude that both the Ion AmpliSeq™ panels and the ForenSeq® Kintelligence Kit were suitable for TAS applied to the human remains in this study.